Bliss GVS Pharma – Breakout Retest with Fresh Momentum (Daily)

is showing a strong bullish structure after a steady uptrend, with price currently holding above key breakout zones and resuming upward momentum. Technical Structure The stock has moved through a classic accumulation → breakout → retest → continuation phase. Key observations: • Prior resistance around ₹220–225 now acting as support • Strong bullish candle with volume expansion • Price sustaining above EMA (~₹211) → trend intact • Formation of higher highs & higher lows • Stoch RSI recovering from mid-zone → momentum building again Key Levels to Watch Immediate resistance: ₹235–245 zone • Sustained breakout above ₹245 → Target 1: ₹270 Target 2: ₹300+ Support levels: • Immediate: ₹210–215 (EMA zone) • Strong support: ₹190–200 Break below ₹190 → trend weakens. Fundamental Perspective Bliss GVS Pharma operates in specialized formulations, particularly in: • Suppositories & pessaries (global niche leadership) • Strong presence in Africa, Asia & emerging markets • Focus on women’s health, anti-infectives & chronic therapies Key positives: • Export-driven growth model • Improving product mix → better margins • Expansion into regulated markets (US/EU) can be a trigger • Beneficiary of generic pharma demand globally